Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) insider Edwin Reisz sold 59,217 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $7.38, for a total transaction of $437,021.46. Following the completion of the sale, the insider owned 1,507,826 shares in the company, valued at $11,127,755.88. This represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Aveanna Healthcare Price Performance
Shares of Aveanna Healthcare stock traded up $0.02 during trading on Thursday, hitting $7.42. 3,877,110 shares of the company were exchanged, compared to its average volume of 938,081. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The firm has a 50 day moving average price of $8.48 and a 200 day moving average price of $8.44. The stock has a market capitalization of $1.55 billion, a price-to-earnings ratio of 20.61 and a beta of 2.06.
Analyst Upgrades and Downgrades
AVAH has been the topic of several recent research reports. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Jefferies Financial Group upped their target price on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a report on Tuesday, October 28th. UBS Group raised their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, January 15th. BMO Capital Markets began coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price objective for the company. Finally, Barclays upped their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $11.06.
Institutional Trading of Aveanna Healthcare
A number of institutional investors have recently modified their holdings of AVAH. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare during the 2nd quarter worth approximately $43,000. Lion Street Advisors LLC purchased a new stake in Aveanna Healthcare during the third quarter worth approximately $89,000. MQS Management LLC purchased a new stake in Aveanna Healthcare during the second quarter worth approximately $59,000. EverSource Wealth Advisors LLC increased its position in shares of Aveanna Healthcare by 88,100.0% in the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after acquiring an additional 11,453 shares in the last quarter. Finally, Belvedere Trading LLC purchased a new position in shares of Aveanna Healthcare in the 2nd quarter valued at $62,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Stories
- Five stocks we like better than Aveanna Healthcare
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
